Amalgamated Bank’s Tenaya Therapeutics TNYA Stock Holding History

Amalgamated Bank’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,587	Closed	-$1K	–	3144
2025 Q1	$1K	Hold	1,587	–	–	﹤0.01%	2932
2024 Q4	$2K	Hold	1,587	–	–	﹤0.01%	2922
2024 Q3	$3K	Hold	1,587	–	–	﹤0.01%	2907
2024 Q2	$5K	Buy	1,587 +608	+62%	+$2.51K	﹤0.01%	2808
2024 Q1	$5K	Sell	979 -2,530	-72%	-$12.1K	﹤0.01%	2744
2023 Q4	$11K	Sell	3,509 -291	-8%	-$628	﹤0.01%	2849
2023 Q3	$10K	Hold	3,800	–	–	﹤0.01%	2899
2023 Q2	$22K	Hold	3,800	–	–	﹤0.01%	2698
2023 Q1	$11K	Buy	3,800 +249	+7%	+$700	﹤0.01%	2797
2022 Q4	$7K	Hold	3,551	–	–	﹤0.01%	2911
2022 Q3	$10K	Hold	3,551	–	–	﹤0.01%	2944
2022 Q2	$20K	Buy	3,551 +1,078	+44%	+$8.72K	﹤0.01%	2860
2022 Q1	$29K	Buy	+2,473	New	+$29.9K	﹤0.01%	2697

Other funds holding TNYA

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Amalgamated Bank's TNYA Position: Q2 2025 in Review

Amalgamated Bank sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 1,587 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in TNYA in Q1 2022 and held it in 13 quarters. The position peaked at $29K in Q1 2022. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

Amalgamated Bank reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
Amalgamated Bank sold 1,587 Tenaya Therapeutics shares in Q2 2025, an estimated $1K.
Amalgamated Bank first reported a position in Tenaya Therapeutics in Q1 2022 and held it in 13 quarters.
Amalgamated Bank's Tenaya Therapeutics position peaked at $29K in Q1 2022.
89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.